Navigation Links
National Institutes of Health Chooses Web of Science(R) to Power electronic Scientific Portfolio Assistant (eSPA)
Date:8/3/2009

PHILADELPHIA and LONDON, Aug. 3 /PRNewswire/ -- Thomson Reuters with Discovery Logic, Inc. today announced that the National Institutes of Health (NIH) has chosen Web of Science((R)) data to power the NIH electronic Scientific Portfolio Assistant (eSPA). eSPA is an information technology system designed to assist NIH grants management officials in creating grant portfolios and tracking research outputs and outcomes, including publications and citations.

"Web of Science was chosen because we have a proven history of supporting customers with superior content, tools and services that are critical to advancing scientific research. The real-time access to grants and output data this platform provides is a powerful interface for analyzing grant portfolios," said Keith MacGregor, Executive Vice President, Scientific & Scholarly Research at Thomson Reuters. "We are proud that Web of Science continues to be chosen by NIH and other leading research organizations."

As the prime contractor on this award, Discovery Logic will link Web of Science data to NIH grants, clinical trials, publications, invention reports, patents and other scientific data sources by providing custom software development services, database services and data analytic services. Michael Pollard, Senior Vice President of Discovery Logic, said, "eSPA uses these powerful resources to create an invaluable data-driven decision support tool for NIH leadership and staff."

Web of Science is the world's largest citation database, providing researchers, administrators, faculty and students access to more than 11,000 actively covered, high impact journals and 110,000 conference proceedings, totaling 45 million documents and more than 1 billion cited references.

About National Institutes of Health

The National Institutes of Health (NIH) -- The Nation's Medical Research Agency -- includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.

About Discovery Logic

Discovery Logic(R) is a leading provider of systems, data and analytics for real-time portfolio management, decision support, outcomes tracking, and information visualization. The company provides a unique platform for relating people, organizations, ideas, grants, inventions, patents, publications, and products worldwide. For additional information, go to www.discoverylogic.com.

About Thomson Reuters

Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, scientific, healthcare and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs more than 50,000 people in 93 countries. For more information, go to thomsonreuters.com.


'/>"/>
SOURCE Thomson Reuters
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. International Milk Genomics & Human Health Symposium Speaker Program Announced
2. Yongye International Announces Branded Store Network Increases Over 40% to 5,000 Stores
3. U.S. Federal Trade Commission to Challenge Thoratecs Proposed Acquisition of HeartWare International
4. Peregrine Pharmaceuticals to Present at the Jesup & Lamont 2009 Growth Stock & National Sales Conference
5. Thomson Reuters Announces 2009 Edition of the CMR International Pharmaceutical R&D Factbook
6. Junying Yu, Leading Stem Cell Researcher, Joins Cellular Dynamics International
7. Novavax Announces Appointment of John J. Trizzino as Senior Vice President, International and Government Alliances
8. Miami Beach Real Estate Attorney Opens Miami Real Estate Brokerage for International Luxury Miami Beach Condo Buyers From Distressed Sellers
9. EnVivo Pharmaceuticals Announces Results and Successful Completion of EVP-6124 Phase Ib/IIa Trial at the International Conference on Alzheimers Disease
10. Cellular Dynamics International In-Licenses Key Patent Portfolio for Using Stem Cell-Derived Cells in Drug Testing
11. Studies Presented at International Conference on Alzheimers Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimers Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... , Feb. 24, 2017  Driven by consumers, ... are now the fastest growing categories, finds the ... Actives in Personal Care: Multi-regional Market Analysis and ... management consulting firm Kline. "Biotechnology actives ... make them more effective for skin and hair ...
(Date:2/24/2017)... 2017  OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a ... Key Opinion Leader event to highlight new clinical data ... presentation at the upcoming 2017 ASCO-SITC Immuno-Oncology Symposium and ... be held in-person and via live webcast on Tuesday, ... PST at the Lotte New York Palace Hotel in ...
(Date:2/23/2017)... , Feb. 23, 2017  MIODx announced today ... two key immunotherapy technologies from the University of ... a method to monitor a patient for response ... and CTLA-4.  The second license extends the technology ... is likely to have an immune-related adverse event ...
(Date:2/23/2017)... Baltimore, Maryland (PRWEB) , ... ... ... firm, PathSensors, Inc., announced today that in a published evaluation of multiple ... (PNNL), a U.S. Department of Energy Laboratory, PathSensors’ CANARY® biosensor threat detection ...
Breaking Biology Technology:
(Date:2/9/2017)... , Feb. 9, 2017 The biomass ... analysis of the biomass boiler market globally in terms ... of biomass boilers. The market for biomass boilers has ... type, end-user, application, and country/region. The market based on ... & forest residues, biogas & energy crops, urban residues, ...
(Date:2/8/2017)... , Feb. 7, 2017 Report Highlights ... billion by 2021 from $8.3 billion in 2016 at ... 2016 to 2021. Report Includes - An overview ... global market trends, with data from 2015 and 2016, ... 2021. - Segmentation of the market on the basis ...
(Date:2/3/2017)... SAN ANTONIO , Feb. 3, 2017  Texas Biomedical ... Dr. Larry Schlesinger as the Institute,s ... of Texas Biomed effective May 31, 2017. He is currently ... and Director of the Center for Microbial Interface Biology at ... Dr. Schlesinger as the new President and CEO of Texas ...
Breaking Biology News(10 mins):